GoCompare rejects 'opportunistic' takeover bid by Zoopla owner

Guardian Web |

GoCompare has rejected an unsolicited takeover offer by the owner of Zoopla and uSwitch valuing the business at nearly £420m.

The price comparison group said the proposal “fundamentally undervalues GoCompare and does not reflect the strong growth prospects of the company” and was rejected this month.

It marks the latest unsolicited approach by ZPG this year, according to GoCompare, which said it received an initial offer that valued the company at 110p per share in May.

That proposal was also rejected by GoCompare’s board on the grounds that it undervalued the business and its prospects.

Related: Go Compare: can anyone compare to founder Hayley Parsons?



GoCompare said the most recent proposal by ZPG offered 110p per share in a combination of cash and shares, valuing the company at about £418m. This represented a 16% premium to GoCompare’s closing share price of 95p on 7 November.

But GoCompare said it also represented a discount to its closing share price of 110.5p on 11 October, which was less than one month before ZPG put forward its proposal.

GoCompare said it had made “significant progress” in the year since its separation from Esure Group, and that the board was confident about GoCompare’s full-year prospects.

The company’s share price closed at about 72p on its first day as a separately traded company in November, after the demerger from Esure.

The company’s chair, Sir Peter Wood, said: “ZPG’s proposal is highly opportunistic and fundamentally undervalues the company and its prospects.”

GoCompare shares closed higher by nearly 10%, or 9.25p, at 102p on Tuesday.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

OncoSec Medical Incorporated

OncoSec Medical Inc is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the…

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…